HBK Investments’s Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 FPAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,000
Closed -$33K 734
2022
Q1
$33K Hold
20,000
﹤0.01% 593
2021
Q4
$40K Buy
+20,000
New +$49.4K ﹤0.01% 641

Other funds holding FPAC.WS

HBK Investments's FPAC.WS Position: Q2 2022 in Review

HBK Investments sold out of Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (FPAC.WS) in Q2 2022, closing a stake of 20,000 shares — an estimated $33K sold.

HBK Investments first reported a position in FPAC.WS in Q4 2021 and held it in 2 quarters. The position peaked at $40K in Q4 2021. 35 funds tracked by Wall St. Rank hold FPAC.WS as of Q2 2022.

  • HBK Investments reported no remaining Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • HBK Investments sold 20,000 Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $33K.
  • HBK Investments first reported a position in Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 2 quarters.
  • HBK Investments's Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $40K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.